首页> 外文期刊>Indian Journal of Endocrinology and Metabolism >Comparison of 18F-Fluorocholine positron emission tomography/computed tomography and four-dimensional computed tomography in the preoperative localization of parathyroid adenomas-initial results
【24h】

Comparison of 18F-Fluorocholine positron emission tomography/computed tomography and four-dimensional computed tomography in the preoperative localization of parathyroid adenomas-initial results

机译:甲状旁腺腺瘤术前定位中18F-氟胆碱正电子发射断层扫描/计算机断层扫描与三维计算机断层扫描的比较

获取原文
           

摘要

Objective: We aimed to compare the diagnostic accuracy of 18F-Fluorocholine (FCH)-positron emission tomography/computed tomography (PET/CT) and four-dimensional (4D)- CT in detection and localization of eutopic and ectopic parathyroid adenoma (PA) in patients with hyperparathyroidism. Materials and Methods: Five patients with primary hyperparathyroidism underwent FCH-PET/CT after 60 min of 185 MBq of intravenous 18F-FCH administration. Images were acquired from head to mediastinum at 3 min per bed position. No intravenous contrast was used. All patients underwent 4D-CT within 2 weeks of the FCH-PET/CT, with a precontrast, post contrast arterial, and venous phase with 75 ml intravenous Iohexol 350 followed by 25 ml saline chase. Histopathology was considered as the gold standard. Results: Both modalities showed 100% concordance in the detection of parathyroid lesions. Both FCH-PET/CT and 4D-CT detected 7 lesions in 5 patients, with 4 patients having a single lesion, and 1 patient having three lesions. Of the 7 reported lesions, 4 were eutopic and 3 were ectopic. No additional lesions were detected by either modality in comparison to the other. All 7 specimens were resected and histopathology showed PA/hyperplasia. Conclusion: FCH-PET/CT and 4D-CT are equally efficacious in detection and localization of eutopic and ectopic PA. This may open up the possibility of using FCH-PET/CT in patients with negative conventional imaging who cannot undergo contrast studies.
机译:目的:我们旨在比较18F-氟胆碱(FCH)-正电子发射断层扫描/计算机断层扫描(PET / CT)和二维(4D)-CT在对位和异位甲状旁腺腺瘤(PA)的检测和定位中的诊断准确性甲状旁腺功能亢进症患者。材料与方法:5例原发性甲状旁腺功能亢进患者在静脉注射18F-FCH 185 MBq后60分钟接受FCH-PET / CT检查。每床位置3分钟从头到纵隔采集图像。没有使用静脉造影剂。所有患者均在FCH-PET / CT的2周内接受了4D-CT造影,造影前,造影剂后和静脉相分别为75 ml静脉注射Iohexol 350和25 ml生理盐水。组织病理学被认为是金标准。结果:两种形式在甲状旁腺病变的检测中显示出100%的一致性。 FCH-PET / CT和4D-CT均在5例患者中检测到7个病变,其中4例具有单个病变,1例具有3个病变。在报告的7个病变中,有4个是异位的,3个是异位的。与另一种方式相比,任何一种方式均未检测到其他病变。切除所有7个标本,并且组织病理学显示PA /增生。结论:FCH-PET / CT和4D-CT对异位和异位PA的检测和定位均有效。这可能为无法进行对比研究的传统影像学阴性的患者打开使用FCH-PET / CT的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号